|
SE0104140D0
(sv)
*
|
2001-12-07 |
2001-12-07 |
Astrazeneca Ab |
Novel Compounds
|
|
MX337817B
(es)
*
|
2004-11-04 |
2011-11-04 |
Vertex Pharma |
Pirazolo [1,5-a] pirimidinas de utilidad como inhibidores de proteina quinasas.
|
|
AU2006215386B2
(en)
*
|
2005-02-16 |
2009-06-11 |
Astrazeneca Ab |
Chemical compounds
|
|
JP2008540535A
(ja)
*
|
2005-05-12 |
2008-11-20 |
メルク エンド カムパニー インコーポレーテッド |
チロシンキナーゼ阻害剤
|
|
US20080287437A1
(en)
*
|
2005-05-16 |
2008-11-20 |
Astrazeneca Ab |
Pyrazolylaminopyrimidine Derivatives Useful as Tyrosine Kinase Inhibitors
|
|
WO2007046867A2
(en)
*
|
2005-05-19 |
2007-04-26 |
Xenon Pharmaceuticals Inc. |
Piperidine derivatives and their uses as therapeutic agents
|
|
US8921376B2
(en)
*
|
2005-05-20 |
2014-12-30 |
Vertex Pharmaceuticals Incorporated |
Pyrrolopyridines useful as inhibitors of protein kinase
|
|
TW200800963A
(en)
*
|
2005-10-28 |
2008-01-01 |
Astrazeneca Ab |
Chemical compounds
|
|
ATE525374T1
(de)
|
2005-12-13 |
2011-10-15 |
Incyte Corp |
Heteroarylsubstituierte pyrroloä2,3-büpyridine und pyrroloä2,3-büpyrimidine als januskinaseinhibitoren
|
|
GB0601638D0
(en)
*
|
2006-01-27 |
2006-03-08 |
Merck Sharp & Dohme |
Therapeutic treatment
|
|
US8198448B2
(en)
|
2006-07-14 |
2012-06-12 |
Amgen Inc. |
Fused heterocyclic derivatives and methods of use
|
|
PE20121506A1
(es)
*
|
2006-07-14 |
2012-11-26 |
Amgen Inc |
Compuestos triazolopiridinas como inhibidores de c-met
|
|
US8217177B2
(en)
|
2006-07-14 |
2012-07-10 |
Amgen Inc. |
Fused heterocyclic derivatives and methods of use
|
|
US8987233B2
(en)
|
2006-11-03 |
2015-03-24 |
Pharmacyclics, Inc. |
Bruton's tyrosine kinase activity probe and method of using
|
|
JP5642973B2
(ja)
*
|
2007-03-22 |
2014-12-17 |
バーテックス ファーマシューティカルズ インコーポレイテッドＶｅｒｔｅｘ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃｏｒｐｏｒａｔｅｄ |
Ｊａｋ阻害薬として有用なｎ−複素環式化合物
|
|
WO2008129255A1
(en)
*
|
2007-04-18 |
2008-10-30 |
Astrazeneca Ab |
5-aminopyrazol-3-yl-3h-imidazo [4,5-b] pyridine derivatives and their use for the treatment of cancer
|
|
UA99459C2
(en)
*
|
2007-05-04 |
2012-08-27 |
Астразенека Аб |
9-(pyrazol-3-yl)- 9h-purine-2-amine and 3-(pyraz0l-3-yl)-3h-imidazo[4,5-b]pyridin-5-amine derivatives and their use for the treatment of cancer
|
|
ES2369596T3
(es)
*
|
2007-05-04 |
2011-12-02 |
Astrazeneca Ab |
Derivados de amino-tiazolil-pirimidina y su uso para el tratamiento del cáncer.
|
|
ES2467665T5
(es)
|
2007-06-13 |
2022-11-03 |
Incyte Holdings Corp |
Sales del inhibidor de cinasas Janus (R)-3-(4-(7H-pirrolo[2,3-d]pirimidin-4-il)-1H-pirazol-1-il)-3-ciclopentilpropanonitrilo
|
|
KR20100087298A
(ko)
*
|
2007-09-28 |
2010-08-04 |
교와 핫꼬 기린 가부시키가이샤 |
피부 질환의 예방 및/또는 치료제
|
|
JP5480813B2
(ja)
*
|
2007-11-16 |
2014-04-23 |
インサイト・コーポレイション |
Ｊａｎｕｓキナーゼ阻害剤としての置換複素環
|
|
US7820665B2
(en)
*
|
2007-12-19 |
2010-10-26 |
Amgen Inc. |
Imidazopyridazine inhibitors of PI3 kinase for cancer treatment
|
|
NZ586662A
(en)
*
|
2007-12-19 |
2012-08-31 |
Vertex Pharma |
PYRAZOLO[1,5-a]PYRIMIDINES USEFUL AS JANUS KINASE 2 INHIBITORS
|
|
US8507501B2
(en)
|
2008-03-13 |
2013-08-13 |
The Brigham And Women's Hospital, Inc. |
Inhibitors of the BMP signaling pathway
|
|
KR20110017445A
(ko)
*
|
2008-06-11 |
2011-02-21 |
아스트라제네카 아베 |
암 및 골수증식성 장애의 치료에 유용한 트리시클릭 2,4-디아미노-ｌ,3,5-트리아진 유도체
|
|
WO2010031816A1
(en)
*
|
2008-09-19 |
2010-03-25 |
Nerviano Medical Sciences S.R.L. |
3,4 DIHYDRO-2H-PYRROLO[1,2-a]PYRAZIN-1-ONE DERIVATIVES
|
|
RS53350B
(sr)
|
2008-09-22 |
2014-10-31 |
Array Biopharma, Inc. |
Supstituisana jedinjenja imidazo[1,2-b]piridazina kao inhibitori trk kinaze
|
|
TW201018693A
(en)
*
|
2008-09-30 |
2010-05-16 |
Astrazeneca Ab |
Chemical compounds 496-1p
|
|
BRPI0914404A2
(pt)
*
|
2008-10-31 |
2019-03-06 |
Genentech Inc |
"compostos, composição farmacêutica e método para tratar ou atenuar a gravidade de uma doença ou condição responsiva à inibição da atividade jak quinase em um paciente"
|
|
GB0821913D0
(en)
|
2008-12-02 |
2009-01-07 |
Price & Co |
Antibacterial compounds
|
|
JP6172939B2
(ja)
*
|
2009-05-22 |
2017-08-02 |
インサイト・ホールディングス・コーポレイションＩｎｃｙｔｅ Ｈｏｌｄｉｎｇｓ Ｃｏｒｐｏｒａｔｉｏｎ |
Ｊａｋ阻害薬としての３−［４−（７ｈ−ピロロ［２，３−ｄ］ピリミジン−４−イル）−１ｈ−ピラゾール−１−イル］オクタン−またはヘプタン−ニトリル
|
|
WO2010135650A1
(en)
|
2009-05-22 |
2010-11-25 |
Incyte Corporation |
N-(HETERO)ARYL-PYRROLIDINE DERIVATIVES OF PYRAZOL-4-YL-PYRROLO[2,3-d]PYRIMIDINES AND PYRROL-3-YL-PYRROLO[2,3-d]PYRIMIDINES AS JANUS KINASE INHIBITORS
|
|
CN102448969A
(zh)
*
|
2009-05-28 |
2012-05-09 |
沃泰克斯药物股份有限公司 |
C-met蛋白激酶抑制剂
|
|
SG10201405826RA
(en)
|
2009-06-17 |
2014-12-30 |
Vertex Pharma |
Inhibitors of influenza viruses replication
|
|
UA110324C2
(en)
|
2009-07-02 |
2015-12-25 |
Genentech Inc |
Jak inhibitory compounds based on pyrazolo pyrimidine
|
|
AR077468A1
(es)
|
2009-07-09 |
2011-08-31 |
Array Biopharma Inc |
Compuestos de pirazolo (1,5 -a) pirimidina sustituidos como inhibidores de trk- quinasa
|
|
TW201113285A
(en)
*
|
2009-09-01 |
2011-04-16 |
Incyte Corp |
Heterocyclic derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors
|
|
EP3461824B1
(en)
|
2009-09-04 |
2021-08-25 |
Biogen MA Inc. |
Bruton's tyrosine kinase inhibitors
|
|
PE20130038A1
(es)
|
2010-03-10 |
2013-01-28 |
Incyte Corp |
Derivados de piperidin-4-il azetidina como inhibidores de jak1
|
|
US20130096160A1
(en)
*
|
2010-04-14 |
2013-04-18 |
Secretary, Department Of Health And Human Services |
Arylthiazolyl piperidines and related compounds as modulators of survival motor neuron (smn) protein production
|
|
EP2571878B1
(en)
|
2010-05-17 |
2018-10-17 |
Incozen Therapeutics Pvt. Ltd. |
Novel 3,5-disubstitued-3h-imidazo[4,5-b]pyridine and 3,5- disubstitued -3h-[1,2,3]triazolo[4,5-b]pyridine compounds as modulators of protein kinases
|
|
HUE044025T2
(hu)
|
2010-05-20 |
2019-09-30 |
Array Biopharma Inc |
Makrociklusos vegyületek mint TRK-kináz inhibitorok
|
|
KR102303885B1
(ko)
|
2010-05-21 |
2021-09-24 |
인사이트 홀딩스 코포레이션 |
Ｊａｋ 저해제에 대한 국소 제형
|
|
GB2480814A
(en)
*
|
2010-06-01 |
2011-12-07 |
Summit Corp Plc |
Compounds for the treatment of clostridium difficile-associated disease
|
|
ES2803556T3
(es)
|
2010-06-01 |
2021-01-27 |
Summit Oxford Ltd |
Compuestos para el tratamiento de enfermedades asociadas a clostridium difficile
|
|
EA026201B1
(ru)
|
2010-11-19 |
2017-03-31 |
Инсайт Холдингс Корпорейшн |
Циклобутилзамещенные производные пирролопиридина и пирролопиримидина как ингибиторы jak
|
|
WO2012068440A1
(en)
|
2010-11-19 |
2012-05-24 |
Incyte Corporation |
Heterocyclic-substituted pyrrolopyridines and pyrrolopyrimidines as jak inhibitors
|
|
RU2013132681A
(ru)
*
|
2010-12-16 |
2015-01-27 |
Вертекс Фармасьютикалз Инкорпорейтед |
Ингибиторы репликации вирусов гриппа
|
|
LT2718270T
(lt)
*
|
2011-06-10 |
2022-08-10 |
Merck Patent Gmbh |
Pirimidino ir piridino junginių, turinčių btk inhibitorinį aktyvumą, kompozicijos ir gamybos būdai
|
|
CA2839767A1
(en)
|
2011-06-20 |
2012-12-27 |
Incyte Corporation |
Azetidinyl phenyl, pyridyl or pyrazinyl carboxamide derivatives as jak inhibitors
|
|
JP2014517079A
(ja)
|
2011-06-22 |
2014-07-17 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
Ａｔｒキナーゼ阻害剤として有用な化合物
|
|
UA118010C2
(uk)
|
2011-08-01 |
2018-11-12 |
Вертекс Фармасьютікалз Інкорпорейтед |
Інгібітори реплікації вірусів грипу
|
|
TW201313721A
(zh)
|
2011-08-18 |
2013-04-01 |
Incyte Corp |
作為ｊａｋ抑制劑之環己基氮雜環丁烷衍生物
|
|
WO2013028263A1
(en)
*
|
2011-08-24 |
2013-02-28 |
Glaxosmithkline Llc |
Pyrazolopyrimidine derivatives as pi3 kinase inhibitors
|
|
UA111854C2
(uk)
|
2011-09-07 |
2016-06-24 |
Інсайт Холдінгс Корпорейшн |
Способи і проміжні сполуки для отримання інгібіторів jak
|
|
KR20140144726A
(ko)
|
2012-03-30 |
2014-12-19 |
리젠 파마슈티컬스 소시에떼 아노님 |
C-met 단백질 키나제의 조절제로서의 신규한 3,5-디치환-3h-이미다조[4,5-b]피리딘 및 3,5- 디치환 -3h-[1,2,3]트리아졸로[4,5-b] 피리딘 화합물
|
|
US9193733B2
(en)
|
2012-05-18 |
2015-11-24 |
Incyte Holdings Corporation |
Piperidinylcyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as JAK inhibitors
|
|
AR091273A1
(es)
|
2012-06-08 |
2015-01-21 |
Biogen Idec Inc |
Inhibidores de pirimidinil tirosina quinasa
|
|
CA2882132C
(en)
*
|
2012-08-16 |
2021-07-06 |
The Scripps Research Institute |
Kappa opioid ligands
|
|
RS62329B1
(sr)
|
2012-11-15 |
2021-10-29 |
Incyte Holdings Corp |
Dozni oblici ruksolitiniba sa produženim vremenom oslobađanja
|
|
WO2014081996A1
(en)
*
|
2012-11-23 |
2014-05-30 |
Glaxosmithkline Llc |
Novel compounds as diacylglycerol acyltransferase inhibitors
|
|
TR201807740T4
(tr)
|
2012-12-07 |
2018-06-21 |
Vertex Pharma |
ATR kinaz inhibitörü olarak 2-amino-6-fluoro-n-(5-fluoro-4-(4-(4-(oksetan-3-il)piperazin-1-karbonil)piperidin-1-il)piridin-3-il)pirazolo[1,5alfa]pirimidin-3-karboksamid.
|
|
TW201501713A
(zh)
*
|
2013-03-01 |
2015-01-16 |
Kyowa Hakko Kirin Co Ltd |
眼炎症性疾病之預防及／或治療劑
|
|
TR201820520T4
(tr)
|
2013-03-06 |
2019-01-21 |
Incyte Holdings Corp |
Bir jak inhibitörü yapmaya yönelik prosesler ve ara ürünler.
|
|
US9682983B2
(en)
|
2013-03-14 |
2017-06-20 |
The Brigham And Women's Hospital, Inc. |
BMP inhibitors and methods of use thereof
|
|
WO2014143241A1
(en)
|
2013-03-15 |
2014-09-18 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of atr kinase
|
|
EP2970286A1
(en)
|
2013-03-15 |
2016-01-20 |
Vertex Pharmaceuticals Inc. |
Fused pyrazolopyrimidine derivatives useful as inhibitors of atr kinase
|
|
EP2970288A1
(en)
*
|
2013-03-15 |
2016-01-20 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of atr kinase
|
|
WO2014175370A1
(ja)
*
|
2013-04-25 |
2014-10-30 |
塩野義製薬株式会社 |
ピロリジン誘導体およびそれらを含有する医薬組成物
|
|
DK3030227T3
(da)
|
2013-08-07 |
2020-04-20 |
Incyte Corp |
Vedvarende frigivelses-doseringsformer for en jak1-inhibitor
|
|
PT3068776T
(pt)
|
2013-11-13 |
2019-08-26 |
Vertex Pharma |
Inibidores da replicação de vírus da gripe
|
|
WO2015073481A1
(en)
|
2013-11-13 |
2015-05-21 |
Vertex Pharmaceuticals Incorporated |
Methods of preparing inhibitors of influenza viruses replication
|
|
WO2015073267A1
(en)
*
|
2013-11-15 |
2015-05-21 |
Calitor Sciences, Llc |
Substituted heteroaryl compounds and methods of use
|
|
CN104650092B
(zh)
*
|
2013-11-16 |
2017-11-10 |
广东东阳光药业有限公司 |
取代的杂芳基化合物及其组合物和用途
|
|
WO2015085132A1
(en)
|
2013-12-06 |
2015-06-11 |
Vertex Pharmaceuticals Incorporated |
2-amino-6-fluoro-n-[5-fluoro-pyridin-3-yl]pyrazolo[1,5-a]pyrimidin-3-carboxamide compound useful as atr kinase inhibitor, its preparation, different solid forms and radiolabelled derivatives thereof
|
|
UA121658C2
(uk)
|
2014-05-23 |
2020-07-10 |
Ф. Хоффманн-Ля Рош Аг |
Сполуки 5-хлордифторметоксифенілпіразолопіримідину як інгібітори янус-кінази
|
|
WO2015184305A1
(en)
|
2014-05-30 |
2015-12-03 |
Incyte Corporation |
TREATMENT OF CHRONIC NEUTROPHILIC LEUKEMIA (CNL) AND ATYPICAL CHRONIC MYELOID LEUKEMIA (aCML) BY INHIBITORS OF JAK1
|
|
SI3152212T1
(sl)
|
2014-06-05 |
2020-06-30 |
Vertex Pharmaceuticals Inc. |
Radioaktivno označeni derivati 2-amino-6-fluoro-N-(5-fluoro-piridin-3-IL)-pirazolo (1,5-A)pirimidin-3- karboksamidne spojine, koristni kot inhibitor kinaze ATR, priprava navedene spojine in njene različne trdne oblike
|
|
LT3157566T
(lt)
|
2014-06-17 |
2019-08-12 |
Vertex Pharmaceuticals Incorporated |
Vėžio gydymo būdas, panaudojant chk1 ir atr inhibitorių derinį
|
|
US10513521B2
(en)
|
2014-07-15 |
2019-12-24 |
The Brigham And Women's Hospital, Inc. |
Compositions and methods for inhibiting BMP
|
|
FI3699181T3
(fi)
|
2014-11-16 |
2023-03-28 |
Array Biopharma Inc |
Kiteinen muoto (s)-n-(5-((r)-2-(2,5-diluorifenyyli)-pyrrolidin-1-yyli)-pyratsolo[1,5-a]pyrimidin-3-yyli)-3-hydroksipyrrolidiini-1-karboksamidivetyysulfaatista
|
|
EP3294735B8
(en)
|
2015-05-13 |
2022-01-05 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of influenza viruses replication
|
|
JP6704416B2
(ja)
|
2015-05-13 |
2020-06-03 |
バーテックス ファーマシューティカルズ インコーポレイテッドＶｅｒｔｅｘ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃｏｒｐｏｒａｔｅｄ |
インフルエンザウイルスの複製の阻害剤を調製する方法
|
|
AU2016331955B2
(en)
|
2015-09-30 |
2022-07-21 |
Vertex Pharmaceuticals Incorporated |
Method for treating cancer using a combination of DNA damaging agents and ATR inhibitors
|
|
EP3368039A1
(en)
|
2015-10-26 |
2018-09-05 |
The Regents of The University of Colorado, A Body Corporate |
Point mutations in trk inhibitor-resistant cancer and methods relating to the same
|
|
US10045991B2
(en)
|
2016-04-04 |
2018-08-14 |
Loxo Oncology, Inc. |
Methods of treating pediatric cancers
|
|
RS65987B1
(sr)
|
2016-04-04 |
2024-10-31 |
Loxo Oncology Inc |
Tečne formulacije (s)-n-(5-((r)-2-(2,5-difluorofenil)-pirolidin-1-il)-pirazolo[1,5-]pirimidin-3-il)-3-hidroksipirolidin-1-karboksamida
|
|
EP3800189B1
(en)
|
2016-05-18 |
2023-06-28 |
Loxo Oncology, Inc. |
Preparation of (s)-n-(5-((r)-2-(2,5-difluorophenyl)pyrrolidin-1-yl)pyrazolo[1,5-a]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide
|
|
KR102700233B1
(ko)
|
2016-07-18 |
2024-08-28 |
유니버시티 헬스 네트워크 |
고체 형태의 ttk 억제제
|
|
US11174243B2
(en)
|
2016-07-21 |
2021-11-16 |
Sunesis Pharmaceuticals, Inc. |
Succinate forms and compositions of Bruton's tyrosine kinase inhibitors
|
|
JOP20190092A1
(ar)
|
2016-10-26 |
2019-04-25 |
Array Biopharma Inc |
عملية لتحضير مركبات بيرازولو[1، 5-a]بيريميدين وأملاح منها
|
|
JOP20190213A1
(ar)
|
2017-03-16 |
2019-09-16 |
Array Biopharma Inc |
مركبات حلقية ضخمة كمثبطات لكيناز ros1
|
|
CA3059232A1
(en)
*
|
2017-04-27 |
2018-11-01 |
The Brigham And Women's Hospital, Inc. |
Novel alk2 inhibitors and methods for inhibiting bmp signaling
|
|
PL233595B1
(pl)
*
|
2017-05-12 |
2019-11-29 |
Celon Pharma Spolka Akcyjna |
Pochodne pirazolo[1,5-a]pirymidyny jako inhibitory kinazy JAK
|
|
CR20190520A
(es)
|
2017-05-22 |
2020-01-21 |
Hoffmann La Roche |
Composiciones y compuestos terapéuticos y métodos para utilizarlos
|
|
WO2019113487A1
(en)
|
2017-12-08 |
2019-06-13 |
Incyte Corporation |
Low dose combination therapy for treatment of myeloproliferative neoplasms
|
|
CN111867581B
(zh)
|
2018-01-29 |
2023-12-26 |
默克专利股份有限公司 |
Gcn2抑制剂及其用途
|
|
TWI816742B
(zh)
*
|
2018-01-29 |
2023-10-01 |
美商維泰克斯製藥公司 |
Gcn2抑制劑及其用途
|
|
WO2019152374A1
(en)
|
2018-01-30 |
2019-08-08 |
Incyte Corporation |
Processes for preparing (1 -(3-fluoro-2-(trifluoromethyl)isonicotinyl)piperidine-4-one)
|
|
CA3095487A1
(en)
|
2018-03-30 |
2019-10-03 |
Incyte Corporation |
Treatment of hidradenitis suppurativa using jak inhibitors
|
|
CA3117695A1
(en)
|
2018-10-26 |
2020-04-30 |
Keros Therapeutics, Inc. |
Crystal forms of an alk2 inhibitor
|
|
BR112021011948A2
(pt)
|
2018-12-20 |
2021-09-08 |
Incyte Corporation |
Compostos de imidazopiridazina e imidazopiridina e usos dos mesmos
|
|
US11833155B2
(en)
|
2020-06-03 |
2023-12-05 |
Incyte Corporation |
Combination therapy for treatment of myeloproliferative neoplasms
|
|
WO2022098812A1
(en)
|
2020-11-04 |
2022-05-12 |
Keros Therapeutics, Inc. |
Methods of treating iron overload
|
|
EP4392418A4
(en)
*
|
2021-08-24 |
2025-06-18 |
The Johns Hopkins University |
Compositions and methods for treating proteotoxicity-associated diseases
|
|
CN116987083A
(zh)
*
|
2022-04-25 |
2023-11-03 |
杭州健崃生物科技有限公司 |
吡唑并[1,5-a]嘧啶衍生物及其制备方法和用途
|
|
KR20240155634A
(ko)
|
2023-04-20 |
2024-10-29 |
한국화학연구원 |
신규한 헤테로고리 화합물 또는 이의 약학적으로 허용가능한 염 및 이를 유효성분으로 포함하는 바이러스성 질환의 예방 또는 치료용 약학적 조성물
|